TeraWulf Secures Long-Term Ground Lease at Cayuga Site to Expand High-Performance Computing Infrastructure
Globenewswire· 2025-08-14 11:05
Core Insights - TeraWulf has executed an 80-year ground lease for approximately 183 acres at the Cayuga site in Lansing, New York, aimed at expanding its high-performance computing (HPC) and AI data center hosting capabilities [1][2][3] Group 1: Lease Details - The Cayuga Ground Lease grants TeraWulf exclusive rights to develop up to 400 MW of digital infrastructure capacity, with 138 MW of low-cost, predominantly zero-carbon power expected to be operational by 2026 [2][3] - The lease includes reciprocal purchase and sale options for $100 starting in year 50, indicating a long-term strategic investment [2] Group 2: Infrastructure and Energy Profile - The Cayuga site benefits from existing electrical infrastructure, an industrial-scale water intake system, and redundant fiber connectivity, essential for enterprise-scale computing workloads [2] - Nearly 90% of the electricity generation mix in Upstate New York comes from zero-carbon sources, providing TeraWulf with one of the cleanest energy profiles in the country [3] - Electricity costs at the site average below $0.05 per kilowatt-hour, supporting TeraWulf's low-cost operating model [3] Group 3: Financial Aspects - The transaction involves a consideration of $95 million in TeraWulf common stock and $3 million in cash to Cayuga's parent company, reinforcing alignment between management and shareholders [4] - The deal was approved by an independent committee of the Board of Directors, ensuring governance and fairness in the transaction [4] Group 4: Company Overview - TeraWulf specializes in developing, owning, and operating environmentally sustainable, industrial-scale data center infrastructure in the U.S., focusing on HPC hosting and bitcoin mining [5]
Cyngn Names Natalie Russell as Chief Financial Officer
Prnewswire· 2025-08-14 11:05
Core Viewpoint - Cyngn Inc. has announced the promotion of Natalie Russell to Chief Financial Officer (CFO), highlighting her extensive experience and expertise in accounting and financial processes as crucial for the company's growth strategy in the autonomous vehicle sector [1][2][3]. Group 1: Leadership Announcement - Natalie Russell has been promoted to CFO of Cyngn, effective immediately [1][2]. - Russell joined Cyngn in March 2023 as Director of Accounting and previously worked as a Technical Accounting Manager at SOAProjects, Inc. [2]. - She has a background in audit and assurance from Ernst & Young and is a Certified Public Accountant in California [1]. Group 2: Company Overview - Cyngn develops and deploys autonomous vehicle technology aimed at industrial organizations, addressing challenges such as labor shortages and safety incidents [4]. - The company's DriveMod technology allows customers to integrate self-driving technology into their operations with minimal upfront costs [5]. Group 3: Product Details - DriveMod Tugger can haul up to 12,000 lbs and has a typical payback period of less than 2 years [6]. - DriveMod Forklift is designed for heavy loads using non-standard pallets and is currently available to select customers [6].
3 Companies That Will Profit From Trump's Semiconductor Tariffs
MarketBeat· 2025-08-14 11:02
Industry Overview - The tech sector has shown strong performance, finishing first or second among the S&P 500's 11 sectors five times in the past eight years, with gains of 57.8% in 2023 and 36.6% in 2024 [1] - The current year has seen a 14.36% gain in the tech sector, second only to industrials' 14.47% [1] - The explosive demand for AI components and infrastructure has significantly contributed to the sector's recent success [2] Company Insights: Advanced Micro Devices (AMD) - AMD has a market cap of $279.58 billion and operates through various segments including data center, client, gaming, and embedded solutions [4] - In Q2 earnings, AMD reported revenue of $7.69 billion, a 31.70% year-over-year growth, despite missing EPS estimates by 6 cents [5] - The company is experiencing robust demand for its CPUs, particularly in the AI product portfolio, with record sales in server and PC processors [5] - Analysts estimate that AMD's business in China could generate $3 billion per quarter from sales of its MI308 chip, despite the export tax imposed [7] Company Insights: Micron Technology - Micron reported Q3 revenue of $9.30 billion, exceeding estimates of $8.83 billion, with an EPS of $1.91 compared to estimates of $1.57 [8][9] - The company noted that data center revenue more than doubled year-over-year, and it expects to grow revenue by 15% [9] - Micron is expanding its U.S. footprint with the construction of the largest chip fabrication plant in the U.S., expected to be operational by 2026 [9] Company Insights: Broadcom - Broadcom's market cap has positioned it as the seventh largest publicly traded company, with a focus on semiconductor solutions [11] - In Q2, Broadcom reported quarterly revenue of $15 billion, a 20.2% year-over-year increase, and returned $7 billion to shareholders [12] - The company provided Q3 guidance of $15.8 billion in revenue, including $5.1 billion from its AI semiconductor business line, marking ten consecutive quarters of growth [13]
BrainStorm Cell Therapeutics Announces Second Quarter 2025 Financial Results and Provides Corporate Update
Prnewswire· 2025-08-14 11:02
Core Insights - BrainStorm Cell Therapeutics Inc. reported financial results for Q2 2025 and provided updates on its clinical development plan for NurOwn, a therapy for neurodegenerative diseases, particularly ALS [1][2] Clinical Development - The FDA has granted clearance for BrainStorm to initiate a Phase 3b clinical trial of NurOwn, named ENDURANCE, which aims to enroll approximately 200 participants at leading academic medical centers [4] - The trial will consist of a 24-week randomized, double-blind, placebo-controlled phase followed by a 24-week open-label extension, with the primary endpoint being the change in the ALS Functional Rating Scale-Revised (ALSFRS-R) from baseline to week 24 [4] - A Citizen Petition has been submitted to the FDA by the ALS community for a new review of NurOwn data, which the company supports as an opportunity to reaffirm the therapy's potential [4] Financial Performance - As of June 30, 2025, BrainStorm reported cash, cash equivalents, and restricted cash of approximately $1.03 million [4] - Research and development expenditures for Q2 2025 were $1.1 million, an increase from $0.9 million in Q2 2024 [4] - General and administrative expenses decreased to approximately $1.4 million in Q2 2025 from approximately $2.1 million in Q2 2024 [4] Survival Data - New survival data from the NurOwn Expanded Access Program indicated that 100% of participants (10 out of 10) survived more than 5 years from the onset of ALS symptoms, compared to an estimated 10% survival rate for ALS patients [4] - The median survival observed in the EAP cohort was 6.8 years from symptom onset, with a range of 6 to 7 years [4] Manufacturing and Partnerships - BrainStorm has signed a Letter of Intent with Minaris Advanced Therapies for the manufacturing of NurOwn for the upcoming Phase 3b clinical trial [4] - The NurOwn data was selected for presentation at the ISCT 2025 Meeting, highlighting the impact of the UNC13A genotype on clinical outcomes for ALS patients treated with NurOwn [4] Company Overview - BrainStorm Cell Therapeutics Inc. specializes in developing autologous adult stem cell therapies for neurodegenerative diseases, with its proprietary NurOwn platform utilizing mesenchymal stem cells to produce neurotrophic factor-secreting cells [6][7]
4 Factors That Could Give Small-Cap ETFs a Boost Ahead
ZACKS· 2025-08-14 11:01
Small-cap stocks, as indicated by the Russell 2000 Index, have lagged their bigger peers so far this year. Small-cap exchange-traded fund (ETF) iShares Russell 2000 (IWM) is up about 3.7% this year compared with gains of about 10% in the S&P 500, 13% in the Nasdaq-100 ETF (QQQ) and 5% in the Dow Jones.And why not? While higher borrowing costs have weighed on the small caps’ capital expenditure, inflationary fears have dampened consumer confidence. After such a lackluster performance, can small caps turn ar ...
Wall Street Breakfast Podcast: Bullish Soars 84% On Debut
Seeking Alpha· 2025-08-14 10:52
Group 1: Bullish (BLSH) IPO - Bullish (NYSE:BLSH) shares surged 84% on their first trading day after raising $1.1 billion in an IPO, with the stock reaching a high of $117.93, more than triple the IPO price [3] - Company insiders benefited significantly, with co-founder Brendan Blumer holding a 30.1% stake valued at $3.4 billion, while board member Kokuei Yuan owns 26.7% worth $3.1 billion [4] Group 2: DeepSeek AI Model Delay - Chinese AI firm DeepSeek has delayed the launch of its new AI model, R2, due to challenges in training with Huawei chips and limited access to Nvidia's high-end GPUs [5] - CEO Liang Wenfeng has not set a release date for R2, expressing dissatisfaction with its performance [6] Group 3: Amazon Grocery Delivery Expansion - Amazon (NASDAQ:AMZN) announced a major expansion of its grocery delivery service, allowing customers in over 1,000 locations to order fresh groceries for same-day delivery, with plans to extend this to over 2,300 locations by year-end [7][8] - The expansion includes thousands of perishable items, enhancing the existing logistics network and offering free same-day delivery for Prime members on orders over $25 in most cities [9] - This development could significantly impact various retailers, including Walmart, Target, and Kroger, as Amazon increases its presence in the grocery sector [10]
Timken Names Michael A. Discenza Chief Financial Officer
Prnewswire· 2025-08-14 10:51
Core Viewpoint - The Timken Company has appointed Michael A. Discenza as the new vice president and chief financial officer, effective immediately, succeeding Philip D. Fracassa who is leaving for another opportunity [1][3]. Company Overview - The Timken Company is a global technology leader in engineered bearings and industrial motion, with a history of over 125 years in innovation and customer-centric solutions [3]. - In 2024, Timken reported sales of $4.6 billion and employs approximately 19,000 people across 45 countries [3]. Leadership Transition - Michael A. Discenza has 25 years of experience at Timken, including the last 10 years as vice president of finance and group controller [1][2]. - Richard G. Kyle, president and CEO, expressed confidence in Discenza's leadership abilities to drive growth and performance within the company [2]. Discenza's Background - Discenza has held various financial and accounting leadership roles since joining Timken in 2000, demonstrating extensive industry knowledge and financial expertise [2]. - He holds both bachelor's and master's degrees in economics from The University of Akron and is a certified management accountant [2].
Dillard’s, Inc. Reports Second Quarter and Year-to-Date Results
Globenewswire· 2025-08-14 10:50
Core Viewpoint - Dillard's, Inc. reported a modest increase in sales for the second quarter of 2025, with net income slightly down compared to the previous year, indicating a mixed performance in a challenging retail environment [1][2]. Second Quarter Results - Net income for the 13 weeks ended August 2, 2025, was $72.8 million, or $4.66 per share, compared to $74.5 million, or $4.59 per share, for the same period in 2024 [2][18]. - Net sales for the quarter were $1.514 billion, up from $1.490 billion in the prior year [3][18]. - Total retail sales, excluding the construction business, increased by 1% to $1.447 billion compared to $1.426 billion in the previous year [4][18]. - Comparable store sales also increased by 1% during the same period [4][18]. Gross Margin - Consolidated gross margin for the second quarter was 36.6% of sales, down from 37.6% in the prior year [5][18]. - Retail gross margin was 38.1% of sales, compared to 39.1% in the previous year, with variations across product categories [6][18]. Inventory and Expenses - Inventory increased by 2% as of August 2, 2025, compared to the previous year [7][18]. - Selling, general, and administrative expenses for the quarter were $434.2 million, representing 28.7% of sales, slightly down from 29.1% in the prior year [8][18]. 26-Week Results - For the 26 weeks ended August 2, 2025, net income was $236.7 million, or $15.08 per share, down from $254.5 million, or $15.68 per share, in the same period in 2024 [11][18]. - Net sales for the 26 weeks were $3.043 billion, slightly up from $3.039 billion in the previous year [12][18]. - Total retail sales for the 26 weeks were flat at $2.915 billion compared to $2.919 billion in the prior year [12][18]. - Retail gross margin for the 26 weeks was 41.8% of sales, down from 42.7% in the previous year [13][18]. Share Repurchase - During the second quarter, the company repurchased $9.8 million worth of Class A Common Stock, and $107.8 million during the 26 weeks, with remaining authorization of $165.2 million under the May 2023 program [15][18]. Other Information - Dillard's operates 272 stores across 30 states, including 28 clearance centers, and has an online presence at dillards.com [17][18].
Protalix BioTherapeutics Reports Second Quarter 2025 Financial and Business Results
Prnewswire· 2025-08-14 10:50
Core Viewpoint - Protalix BioTherapeutics reported a significant increase in revenues driven by the sales of Elfabrio® and provided updates on its product pipeline and management changes [2][4][6]. Financial Highlights - Revenues from selling goods for Q2 2025 were $15.4 million, a 16% increase from $13.3 million in Q2 2024, primarily due to an $8.0 million increase in sales to Chiesi [6][7]. - Cost of goods sold decreased by 38% to $5.9 million in Q2 2025 from $9.5 million in Q2 2024 [7]. - Research and development expenses doubled to approximately $6.0 million in Q2 2025 from $3.0 million in Q2 2024, mainly due to preparations for the Phase 2 trial of PRX-115 [7][17]. - Selling, general, and administrative expenses decreased by 26% to $2.6 million in Q2 2025 from $3.5 million in Q2 2024 [7]. - The net income for Q2 2025 was approximately $164,000, compared to a net loss of $2.2 million in Q2 2024 [7][17]. Business Updates - Protalix is advancing the development of PRX-115, with a Phase 2 trial expected to start in the second half of 2025 [2][4]. - The company appointed Gilad Mamlok as the new Chief Financial Officer, succeeding Eyal Rubin, who will assist during the transition until October 2025 [3][6]. - Protalix has been added to the Russell 3000® and Russell 2000® Indexes as of June 27, 2025 [6]. Product Pipeline - Elfabrio® is positioned for growth in the Fabry disease market, which is currently valued at approximately $2.3 billion and is expected to grow to $3.2 billion by 2030 [2][12]. - The European Medicines Agency is reviewing a submission for a new dosing regimen for Elfabrio® [6].
New Strong Sell Stocks for August 14th
ZACKS· 2025-08-14 10:45
Group 1 - Fidelis Insurance Holdings Limited (FIHL) has been added to the Zacks Rank 5 (Strong Sell) List due to a 42.9% downward revision in the Zacks Consensus Estimate for its current year earnings over the last 60 days [1] - Flowco Holdings Inc. (FLOC) is also on the Zacks Rank 5 (Strong Sell) List, with a 3.4% downward revision in the Zacks Consensus Estimate for its current year earnings over the last 60 days [2] - WhiteHorse Finance, Inc. (WHF) has been included in the Zacks Rank 5 (Strong Sell) List, experiencing a 4.1% downward revision in the Zacks Consensus Estimate for its current year earnings over the last 60 days [2]